52 asthmatic patients aged 18 to 70 years took part in a double-blind crossover trial comparing the effects of regular treatment of asthma with inhaled salbutamol ( 400 micrograms qds ) versus irregular treatment ( 400 micrograms prn ) , each prescribed for 4 weeks .
C0004096
asthma
C0001927
salbutamol